In our study, we found that CTSL could proteolytically cleave the CDP/Cux p200 and generate CDP/Cux p110, which contributed to the transcriptional activation of VEGF-D and promoted tumor angiogenesis in GC. The gene discussed is CTSL; the disease is neoplasm.